Fate Therapeutics Inc (FATE)
2.03
-0.19
(-8.56%)
USD |
NASDAQ |
Nov 21, 14:37
Fate Therapeutics Price: 2.03 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 2.16 | 2.35 | 2.03 | 2.22 | 2.372M |
| Nov 19, 2024 | 2.20 | 2.260 | 2.03 | 2.18 | 4.513M |
| Nov 18, 2024 | 2.26 | 3.50 | 2.23 | 2.27 | 24.75M |
| Nov 15, 2024 | 2.11 | 2.115 | 1.96 | 2.02 | 1.753M |
| Nov 14, 2024 | 2.18 | 2.22 | 2.05 | 2.08 | 1.798M |
| Nov 13, 2024 | 2.45 | 2.555 | 2.15 | 2.17 | 1.764M |
| Nov 12, 2024 | 2.52 | 2.56 | 2.38 | 2.38 | 1.118M |
| Nov 11, 2024 | 2.46 | 2.58 | 2.375 | 2.56 | 1.199M |
| Nov 08, 2024 | 2.52 | 2.57 | 2.33 | 2.42 | 1.959M |
| Nov 07, 2024 | 2.79 | 2.79 | 2.51 | 2.55 | 1.220M |
| Nov 06, 2024 | 2.81 | 2.89 | 2.665 | 2.79 | 1.911M |
| Nov 05, 2024 | 2.81 | 2.81 | 2.495 | 2.68 | 1.294M |
| Nov 04, 2024 | 2.40 | 2.79 | 2.31 | 2.76 | 2.250M |
| Nov 01, 2024 | 2.42 | 2.481 | 2.32 | 2.43 | 1.812M |
| Oct 31, 2024 | 2.49 | 2.50 | 2.27 | 2.37 | 1.829M |
| Oct 30, 2024 | 2.70 | 2.71 | 2.47 | 2.49 | 1.239M |
| Oct 29, 2024 | 2.87 | 2.88 | 2.665 | 2.72 | 1.126M |
| Oct 28, 2024 | 2.70 | 2.87 | 2.67 | 2.87 | 2.213M |
| Oct 25, 2024 | 2.81 | 2.81 | 2.64 | 2.65 | 2.066M |
| Oct 24, 2024 | 3.03 | 3.04 | 2.80 | 2.81 | 1.019M |
| Oct 23, 2024 | 3.17 | 3.21 | 3.00 | 3.03 | 1.053M |
| Oct 22, 2024 | 3.14 | 3.24 | 3.08 | 3.19 | 609634.0 |
| Oct 21, 2024 | 3.21 | 3.25 | 3.075 | 3.15 | 1.846M |
| Oct 18, 2024 | 3.23 | 3.32 | 3.185 | 3.23 | 741041.0 |
| Oct 17, 2024 | 3.19 | 3.265 | 3.110 | 3.22 | 753337.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.65
Minimum
Oct 27 2023
117.40
Maximum
Jan 14 2021
30.92
Average
24.18
Median
Apr 07 2020
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.70 |
| Palatin Technologies Inc | 0.9146 |
| iBio Inc | 2.39 |
| Theriva Biologics Inc | 1.24 |
| Oragenics Inc | 0.27 |
Price Related Metrics
| PS Ratio | 16.42 |
| Price to Book Value | 0.6381 |
| Earnings Yield | -81.28% |
| Market Cap | 231.21M |